Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New Poteintial Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
Cuprizone decreases intermediate and late-stage progenitor cells in hippocampal neurogenesis of rats in a framework of 28-day oral dose toxicity study.
Single-Institution Retrospective Series of Gamma Knife Radiosurgery in the Treatment of Multiple Sclerosis-Related Trigeminal Neuralgia: Factors that Predict Efficacy.
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis.
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
Bone marrow derived elements and resident microglia in brain inflammation.
Cross-sectional area variations of internal jugular veins during supine head rotation in multiple sclerosis patients with chronic cerebrospinal venous insufficiency: a prospective diagnostic controlled study with duplex ultrasound investigation.
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Cerebral venous thrombosis in a patient with clinically isolated spinal cord syndrome.
Therapeutic strategies targeting B-cells in multiple sclerosis.
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
Improving reporting of multiple sclerosis relapse.
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.
Investigation-Directed Approach to Inflammatory Optic Neuropathies.
Scale Adjustments to Facilitate Two-Dimensional Measurements in OCT Images.
[Evaluation of the autonomic regulation of the cardiac oxygen supply of measured physical activity in patients with remitting multiple sclerosis.]
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
Pages
« first
‹ previous
…
529
530
531
532
533
534
535
536
537
…
next ›
last »